NCT06415864View on ClinicalTrials.gov

Oral Cladribine B-cell Study

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

January 31, 2024

Study Completion Date

January 31, 2024

Conditions
Multiple Sclerosis
Trial Locations (1)

Unknown

Barts Health NHS Trust, London

All Listed Sponsors
lead

Queen Mary University of London

OTHER

NCT06415864 - Oral Cladribine B-cell Study | Biotech Hunter | Biotech Hunter